Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07645209
A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold RegionsChina-Japan Union Hospital, Jilin UniversityActive Not Recruiting
NCT07645209Active Not Recruiting
—
A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Canc...China-Japan Union Hospita...
NCT07645534
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.Valenta Pharm JSCRecruitingPhase 1
NCT07645534Recruiting
Phase 1
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta...Valenta Pharm JSC
NCT07645443
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early PsychosisCentral Institute of Mental Health, MannheimRecruitingNot Applicable
NCT07645443Recruiting
Not Applicable
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adu...Central Institute of Ment...
NCT07644949
Self-Help Plus (SH+) for Stress Reduction in Social Service Workers: A Pilot RCTIstanbul Medeniyet UniversityNot Yet RecruitingNot Applicable
NCT07644949Not Yet Recruiting
Not Applicable
Self-Help Plus (SH+) for Stress Reduction in Social Service Workers: A Pilot RCTIstanbul Medeniyet Univer...
NCT07644156
The Impact of Physical Exercise on Working Memory in Elderly People With Mild Cognitive ImpairmentShanghai University of SportEnrolling By InvitationNot Applicable
NCT07644156Enrolling By Invitation
Not Applicable
The Impact of Physical Exercise on Working Memory in Elderly People With Mild Co...Shanghai University of Sp...
NCT07645001
Therapeutic Synergy of Probiotic Augmented Conventional Antidiabetic Pharmacotherapy in Gestational Diabetes MellitusRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07645001Not Yet Recruiting
Not Applicable
Therapeutic Synergy of Probiotic Augmented Conventional Antidiabetic Pharmacothe...Riphah International Univ...
NCT07646080
Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma ProtuberansYanjie Zhang, MDNot Yet RecruitingPhase 2
NCT07646080Not Yet Recruiting
Phase 2
Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemothera...Yanjie Zhang, MD
NCT07645027
Low Volume Nose Resistance Breathing Exercise With Incentive Spirometer in Patient With Cervical Spinal Cord InjuriesRiphah International UniversityRecruitingNot Applicable
NCT07645027Recruiting
Not Applicable
Low Volume Nose Resistance Breathing Exercise With Incentive Spirometer in Patie...Riphah International Univ...
NCT07646418
Combined Effects of LIRT-BFR Therapy in Post- Stroke PatientsRiphah International UniversityRecruitingNot Applicable
NCT07646418Recruiting
Not Applicable
Combined Effects of LIRT-BFR Therapy in Post- Stroke PatientsRiphah International Univ...
NCT07644078
Clinical Examination of Cavovarus FeetRoyal National Orthopaedic Hospital NHS TrustRecruiting
NCT07646262
Gluten-Free vs Mediterranean Diet in Rheumatoid ArthritisHasan Kalyoncu UniversityRecruitingNot Applicable
NCT07646262Recruiting
Not Applicable
Gluten-Free vs Mediterranean Diet in Rheumatoid ArthritisHasan Kalyoncu University
NCT07644975
Electrolytic Surface Decontamination in the Surgical Treatment of Peri-implantitis: A Randomized Clinical TrialIstanbul UniversityNot Yet RecruitingNot Applicable
NCT07644975Not Yet Recruiting
Not Applicable
Electrolytic Surface Decontamination in the Surgical Treatment of Peri-implantit...Istanbul University
NCT07645079
Automated Insulin Delivery Versus Daily Injections for Hospital Diabetes CareSteno Diabetes Center CopenhagenNot Yet RecruitingNot Applicable
NCT07645079Not Yet Recruiting
Not Applicable
Automated Insulin Delivery Versus Daily Injections for Hospital Diabetes CareSteno Diabetes Center Cop...
NCT07643831
Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2- Early or Locally Advanced/Metastatic Breast CancerGenentech, Inc.Unknown
NCT07643831Unknown
—
Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2-...Genentech, Inc.
NCT07643805
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCLThe First Affiliated Hospital with Nanjing Medical UniversityNot Yet RecruitingPhase 1
NCT07643805Not Yet Recruiting
Phase 1
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Pat...The First Affiliated Hosp...
NCT07646548
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsRegeneron PharmaceuticalsNot Yet RecruitingPhase 1
NCT07646548Not Yet Recruiting
Phase 1
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Be...Regeneron Pharmaceuticals
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07645378
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South AfricaCentre for the AIDS Programme of Research in South AfricaNot Yet RecruitingNot Applicable
NCT07645378Not Yet Recruiting
Not Applicable
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervica...Centre for the AIDS Progr...
NCT07644039
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced MalignanciesPharmaMarRecruitingPhase 1
NCT07644039Recruiting
Phase 1
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advan...PharmaMar
NCT07644650
Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant TumorsMabsoft Therapeutics (Australia) Pty. Ltd.Not Yet RecruitingPhase 1
NCT07644650Not Yet Recruiting
Phase 1
Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant TumorsMabsoft Therapeutics (Aus...
Result Breakdown
Not yet recruiting9 (45%)
Recruiting8 (40%)
Active, not recruiting1 (5%)
Enrolling by invitation1 (5%)
Unknown1 (5%)
not_applicable10 (50%)
Phase 15 (25%)
Not Specified3 (15%)
Phase 22 (10%)